Comparative Study Of Kasisa Bhasma With Two Different Kasis Containing Formulations And Their Effects On Shwitraroga

A Comparative Pharmaceutico - Clinical Study Of Kasisa Bhasma With Two Different Kasis Containing Formulations And Their Effects On Shwitraroga - NILL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089558

Enrollment

Registered

2025-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for trial. Having classical sign and symptoms along with some modern parameter

Exclusion criteria

Exclusion criteria: Patients suffering from AIDS, CANCER, T.B, Cardiac complications. Patients of spure disease, malabsorption, Hb% below 9g/dl, Pregnant women. Vitiligo patches that rapidly spread and become associated with redness, blister formation. Itching during therapy or as such

Design outcomes

Primary

Measure	Time frame
To Evaluate the effect of Kasisa bhasma and Associated lepa on Shwitra Roga.8 weekTimepoint: To Evaluate the effect of Kasisa bhasma and Associated lepa on Shwitra Roga.8 week	—

Secondary

Measure	Time frame
to study the preparation of safe , effective and quality drug and standardizationTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr prof Prabhat Kumar Dwivedi

Government Ayurvedic college and Hospital Patna

drprabhatkd@gmail.com9431172175

Outcome results